Thorsten Gräf

664 total citations
16 papers, 528 citations indexed

About

Thorsten Gräf is a scholar working on Molecular Biology, Hematology and Immunology and Allergy. According to data from OpenAlex, Thorsten Gräf has authored 16 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Hematology and 3 papers in Immunology and Allergy. Recurrent topics in Thorsten Gräf's work include Hematopoietic Stem Cell Transplantation (4 papers), Acute Myeloid Leukemia Research (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Thorsten Gräf is often cited by papers focused on Hematopoietic Stem Cell Transplantation (4 papers), Acute Myeloid Leukemia Research (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Thorsten Gräf collaborates with scholars based in Germany, United States and Luxembourg. Thorsten Gräf's co-authors include Hans Robert Kalbitzer, Michael Spoerner, Burkhard König, Guido Kobbe, Roland Fenk, Rainer Haas, Ingmar Bruns, Ralf Kronenwett, Alfred Wittinghofer and Lothar Gremer and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Oncogene.

In The Last Decade

Thorsten Gräf

16 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thorsten Gräf Germany 12 278 177 113 51 37 16 528
H Ohtani Japan 13 248 0.9× 69 0.4× 113 1.0× 17 0.3× 50 1.4× 52 616
Chu Myong Seong South Korea 12 360 1.3× 119 0.7× 133 1.2× 9 0.2× 36 1.0× 30 511
Jan Moebius Germany 8 388 1.4× 217 1.2× 45 0.4× 14 0.3× 26 0.7× 11 743
F.D. Böhmer Germany 8 322 1.2× 153 0.9× 108 1.0× 8 0.2× 71 1.9× 13 489
Lata Chauhan United States 8 313 1.1× 116 0.7× 159 1.4× 13 0.3× 32 0.9× 15 489
Christi L. Clogston United States 12 296 1.1× 146 0.8× 75 0.7× 17 0.3× 29 0.8× 12 581
Daniel J. Burdick United States 13 353 1.3× 63 0.4× 77 0.7× 27 0.5× 14 0.4× 19 613
Frederick D. Tsai United States 7 466 1.7× 39 0.2× 80 0.7× 25 0.5× 19 0.5× 12 547
Yingdai Gao China 13 301 1.1× 154 0.9× 86 0.8× 10 0.2× 73 2.0× 42 536
Ute Brassat Germany 8 300 1.1× 52 0.3× 72 0.6× 21 0.4× 60 1.6× 8 468

Countries citing papers authored by Thorsten Gräf

Since Specialization
Citations

This map shows the geographic impact of Thorsten Gräf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thorsten Gräf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thorsten Gräf more than expected).

Fields of papers citing papers by Thorsten Gräf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thorsten Gräf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thorsten Gräf. The network helps show where Thorsten Gräf may publish in the future.

Co-authorship network of co-authors of Thorsten Gräf

This figure shows the co-authorship network connecting the top 25 collaborators of Thorsten Gräf. A scholar is included among the top collaborators of Thorsten Gräf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thorsten Gräf. Thorsten Gräf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Raith, Marianne, Margarete Focke‐Tejkl, Herbert Wank, et al.. (2019). Rational design of a hypoallergenic Phl p 7 variant for immunotherapy of polcalcin-sensitized patients. Scientific Reports. 9(1). 7802–7802. 14 indexed citations
2.
Kuehn, Annette, Christiane Hilger, Thorsten Gräf, & François Hentges. (2017). Protein and DNA-based assays as complementary tools for fish allergen detection. PubMed. 1(2). 120–126. 10 indexed citations
3.
Kuehn, Annette, Christiane Hilger, Thorsten Gräf, & François Hentges. (2012). Protein- und DNS-basierte Methoden als komplementäre Methoden zum Nachweis von Fischallergenen in Nahrungsmitteln. Allergologie. 35(7). 343–350. 6 indexed citations
4.
Gräf, Thorsten, et al.. (2011). Cu2+-cyclen as Probe to Identify Conformational States in Guanine Nucleotide Binding Proteins. Journal of the American Chemical Society. 133(7). 2048–2051. 17 indexed citations
5.
Gräf, Thorsten, Michael Spoerner, Christian Herrmann, et al.. (2010). Stabilizing a Weak Binding State for Effectors in the Human Ras Protein by Cyclen Complexes. Angewandte Chemie International Edition. 49(22). 3830–3833. 98 indexed citations
6.
Gräf, Thorsten, Michael Spoerner, Christian Herrmann, et al.. (2010). Stabilisierung eines niederaffinen Zustands für Effektoren im menschlichen Ras‐Protein durch Cyclenkomplexe. Angewandte Chemie. 122(22). 3918–3922. 15 indexed citations
7.
Czibere, Akos, Ingmar Bruns, Nicolaus Kröger, et al.. (2009). 5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis. Bone Marrow Transplantation. 45(5). 872–876. 75 indexed citations
9.
Gocke, Dörte, et al.. (2009). Comparative characterisation of thiamin diphosphate-dependent decarboxylases. Journal of Molecular Catalysis B Enzymatic. 61(1-2). 30–35. 44 indexed citations
10.
Kuendgen, A., Thorsten Gräf, Fabian Zohren, et al.. (2006). Induction of complete remission in a patient with acute myeloid leukemia refractory to high-dose chemotherapy through treatment with 5-azacytidine. Leukemia Research. 31(3). 407–409. 9 indexed citations
11.
Kronenwett, Ralf, Ulrich Steidl, Frank Neumann, et al.. (2005). Distinct molecular phenotype of malignant CD34+ hematopoietic stem and progenitor cells in chronic myelogenous leukemia. Oncogene. 24(34). 5313–5324. 39 indexed citations
12.
Spoerner, Michael, Thorsten Gräf, Burkhard König, & Hans Robert Kalbitzer. (2005). A novel mechanism for the modulation of the Ras-effector interaction by small molecules. Biochemical and Biophysical Research Communications. 334(2). 709–713. 46 indexed citations
13.
Steidl, Ulrich, Roland Fenk, Ingmar Bruns, et al.. (2004). Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma. Bone Marrow Transplantation. 35(1). 33–36. 68 indexed citations
14.
Rohr, Ulrich‐Peter, Helene Geddert, Wolfram Müller, et al.. (2004). Expression of the tyrosine kinase c‐kit is an independent prognostic factor in patients with small cell lung cancer. International Journal of Cancer. 111(2). 259–263. 35 indexed citations
15.
Kronenwett, Ralf, Thorsten Gräf, Markus Weber, et al.. (2002). Inhibition of angiogenesis in vitro by αv integrin–directed antisense oligonucleotides. Cancer Gene Therapy. 9(7). 587–596. 19 indexed citations
16.
Boleman, S. L., Thorsten Gräf, H. J. Mersmann, et al.. (1998). Pigs Fed Cholesterol Neonatally Have Increased Cerebrum Cholesterol as Young Adults. Journal of Nutrition. 128(12). 2498–2504. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026